CRWEWallstreet.com Stock Report! PWRM, Power 3 Medical Products Inc, PWRM.OB

Posted on 11/8/2009 10:53:42 PM in #Stocks | 0 comments comments

_______________________________________

FREE Daily Stock Alerts From CRWEWallStreet.com

_______________________________________

Power3 Medical Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer biomarkers and diagnostic tests, has announced further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of Personalized Medicine.”

Power3 Medical Products, Inc. (OTCBB: PWRM), is also a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

Power3 Medical Products, Inc. (OTCBB: PWRM), a development stage company, engages in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, amyotrophic lateral sclerosis (ALS), Alzheimer?s disease, and Parkinson?s disease. Its product candidates include BC-SeraPro, a blood serum protein breast cancer test for the diagnosis of breast cancer and to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The company?s products also comprise NuroPro, a blood serum protein neurodegenerative disease diagnostic screening test for disease diagnostics, such as neurological diseases of motor control, such as Parkinson?s disease, ALS, and similarly disorders; ALS specific tests for ALS vs. ALS-like disorders; Alzheimer?s disease specific tests; and a Parkinson?s disease specific test. Power3 Medical Products has a joint venture agreement with NeoGenomics. The company was founded in 1992 and is based in The Woodlands, Texas.

Web Site: http://www.Power3Medical.com

************Advertisement************

************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and expects to receive an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news for Power 3 Medical Products Inc. (PWRM.OB).